[Hyponatremia - carbamazepine medication complications]

Area of Science:

• Endocrinology
• Nephrology
• Clinical Pharmacology

Background:

• Hyponatremia, defined as serum sodium concentration below 135 mmol/l, poses significant clinical challenges, particularly when levels drop below 120 mmol/l.
• Common etiologies include extrarenal and renal sodium losses, endocrine disorders like hypothyroidism and Addison's disease, and pseudohyponatremia.

Observation:

• Clinical manifestations range from fatigue and headache to severe neurological deficits such as delirium and coma.
• Distinguishing between sodium deficiency and pseudohyponatremia is crucial for appropriate management.
• Rapid correction of severe hyponatremia with hypertonic saline solutions carries risks of central nervous system complications.

Findings:

• The study presents two case histories of hyponatremia in elderly female patients attributed to carbamazepine use.
• Hyponatremia developed within 48 hours of initiating carbamazepine, underscoring the potential for rapid-onset adverse effects.
• Treatment guidelines emphasize gradual correction of serum sodium to avoid osmotic demyelination syndrome.

Implications:

• Clinicians should be vigilant for carbamazepine-induced hyponatremia, recognizing its potential for rapid development.
• Careful monitoring and slow correction of serum sodium levels are essential in managing hyponatremia.
• Understanding diverse etiologies and treatment nuances is critical for optimizing patient outcomes in hyponatremia.